- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
 |
| Quantity: | |
|---|---|
Sulfadiazine Sodium
CAS number： 547-32-0
Molecular formula： C10H10N4NaO2S
molecular weight：273.26
Shelf Life: 3 years
Packing: 25kg/drum
Specification:
INSPECTION ITEM | STANDARD | RESULTS OF ANALYSIS |
DESCRIPTION | WHITE OR ALMOST WHITE CRYSTALLINE OR POWDER | |
IDENTIFICATION | A:CHEMICAL METHOD B:TEST FOR SODIUM |
|
HEAVY METALS | ≤20PPM | ＜20PPM |
MELTING POINT | 250 —254°C | 251-252°C |
ACIDITY | PH=9.6-10.5 | 10.10 |
CLARITY OF SOLUTION | 澄清 CLARITY | 澄清 CLARITY |
LOSS ON DRYING | ≤0.5% | 0.06% |
SELENIUM | ≤30PPM | ＜30PPM |
ASSAY(DRIED BASIS) | 99.0-100.5% | 99.50% |
CONCLUSION: THE ABOVE-MENTIONED PRODUCT CONFORMS TO USP34 | ||
Function:
1. It is used to prevent and treat epidemic meningitis caused by sensitive meningococcal bacteria.
2. For the treatment of acute bronchitis, mild pneumonia, otitis media and skin and soft tissue infection caused by sensitive bacteria.
3. For the treatment of star nocardiosis.
4. Can be used as a secondary drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis.
5. Can be used as an adjunct to the treatment of chloroquine-resistant falciparum malaria.
6. Combined with pyrimethamine for the treatment of toxoplasmosis caused by Toxoplasma gondii.
Application
sulfa drug, used to treat the infection caused by staphylococcal bacteria, hemolytic streptococcus, pneumococcus and meningitis coccus, etc.
Sulfadiazine Sodium
CAS number： 547-32-0
Molecular formula： C10H10N4NaO2S
molecular weight：273.26
Shelf Life: 3 years
Packing: 25kg/drum
Specification:
INSPECTION ITEM | STANDARD | RESULTS OF ANALYSIS |
DESCRIPTION | WHITE OR ALMOST WHITE CRYSTALLINE OR POWDER | |
IDENTIFICATION | A:CHEMICAL METHOD B:TEST FOR SODIUM |
|
HEAVY METALS | ≤20PPM | ＜20PPM |
MELTING POINT | 250 —254°C | 251-252°C |
ACIDITY | PH=9.6-10.5 | 10.10 |
CLARITY OF SOLUTION | 澄清 CLARITY | 澄清 CLARITY |
LOSS ON DRYING | ≤0.5% | 0.06% |
SELENIUM | ≤30PPM | ＜30PPM |
ASSAY(DRIED BASIS) | 99.0-100.5% | 99.50% |
CONCLUSION: THE ABOVE-MENTIONED PRODUCT CONFORMS TO USP34 | ||
Function:
1. It is used to prevent and treat epidemic meningitis caused by sensitive meningococcal bacteria.
2. For the treatment of acute bronchitis, mild pneumonia, otitis media and skin and soft tissue infection caused by sensitive bacteria.
3. For the treatment of star nocardiosis.
4. Can be used as a secondary drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis.
5. Can be used as an adjunct to the treatment of chloroquine-resistant falciparum malaria.
6. Combined with pyrimethamine for the treatment of toxoplasmosis caused by Toxoplasma gondii.
Application
sulfa drug, used to treat the infection caused by staphylococcal bacteria, hemolytic streptococcus, pneumococcus and meningitis coccus, etc.
